Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Ambulatory management of bronchopleural fistulae secondary to empyema

J Davy, P Tang, M Burton
European Respiratory Journal 2022 60: 257; DOI: 10.1183/13993003.congress-2022.257
J Davy
East Suffolk and North Essex NHS Foundation Trust, Ipswich, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P Tang
East Suffolk and North Essex NHS Foundation Trust, Ipswich, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M Burton
East Suffolk and North Essex NHS Foundation Trust, Ipswich, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Ambulatory management of pneumothoraces and malignant pleural effusions is common, with occasional use in post-operative patients with persistent air leak. A literature review did not ascertain any prior description of ambulatory management of patients with bronchopleural fistulae secondary to empyema. We present a case series of 2 patients who received ambulatory management who were not suitable for surgical intervention.

Case 1. 69 year-old man admitted with a right hydropneumothorax and mediastinal shift. An empyema was confirmed on chest drain insertion. CT showed a bronchopleural fistula from abscess rupture. After a 4 week hospital stay, an ambulatory chest drain valve was fitted. He received outpatient managment for 2 weeks prior to chest drain removal. Follow up x-rays showed lung re-expansion with small residual pleural effusion.

Case 2. 75 year-old man presented with right lower zone consolidation and associated effusion. He required intubation and transfer to intensive care. A chest drain initially drained pus, then copious bubbling developed. CT showed a right sided pneumothorax, residual empyema and a bronchopleural fistula.

After an 8 week hospital stay, an ambulatory valve was placed and he was reviewed weekly in pleural clinic. He received outpatient management for 2 weeks prior to chest drain removal. Follow up has shown his lung remains re-expanded and he is doing well.

These cases demonstrate that, for certain patients, it is possible to safely manage bronchopleural fistulae secondary to empyema in an outpatient setting. This reduces hospital length of stay, decreases exposure to hospital associated infections and allows patients to recuperate at home with their family.

  • Pleura
  • Treatments
  • Experimental approaches

Footnotes

Cite this article as Eur Respir J 2022; 60: Suppl. 66, 257.

This article was presented at the 2022 ERS International Congress, in session “-”.

This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).

  • Copyright ©the authors 2022
Previous
Back to top
Vol 60 Issue suppl 66 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Ambulatory management of bronchopleural fistulae secondary to empyema
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Ambulatory management of bronchopleural fistulae secondary to empyema
J Davy, P Tang, M Burton
European Respiratory Journal Sep 2022, 60 (suppl 66) 257; DOI: 10.1183/13993003.congress-2022.257

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Ambulatory management of bronchopleural fistulae secondary to empyema
J Davy, P Tang, M Burton
European Respiratory Journal Sep 2022, 60 (suppl 66) 257; DOI: 10.1183/13993003.congress-2022.257
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • SPRINTER: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Determine the Efficacy and Safety of Inhaled Interferon Beta-1a (SNG001) for the Treatment of Patients Hospitalised Due to COVID-19 (NCT04732949)
  • A randomised controlled trial of early intervention with oral favipiravir in patients hospitalised with COVID-19 (PIONEER Trial)
  • Dipeptidyl Peptidase-1 Inhibition in Patients Hospitalized with COVID-19: a Multicentre Randomized Double-Blind Placebo Controlled Trial
Show more 10.01 - Respiratory infections and bronchiectasis

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society